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Paleovirology is a relatively new branch of Evolutionary Biology dedicated to the study of ancient 
viruses and their impact on host biology. Host genomes are amazing adept at challenging viral 
infection both short-term (immediate immune responses) and long-term (co-evolution with viral 
proteins). The existence of ancient genomic changes in host anti-viral factor encoding genes can 
have strong implications about the viruses that infected the primate lineage. These genomic 
changes, usually advantageous at the time of their birth, helped to shape the modern primate 
immune system. 
Of the plethora of genes that contribute to a host’s innate immune response to viral infection, the 
protein encoded by the TRIM5gene is of particular importance. TRIM5 is a retroviral restriction factor 
that limits the life cycle of several retroviruses by binding the viral capsid protein. Modifications in 
theTRIM5 locus in a range of primate and non-primate species throughout evolution has 
made TRIM5 better able to inhibit viral infection. These modifications include point mutations in the 
capsid-binding coiled-coil domain of TRIM5, as well as novel TRIM5gene fusions, that allowed 
TRIM5 to retain robust capsid binding. TRIMCypA1, a recently discovered TRIM5 gene fusion event 
with retrotransposed Cyclophilin A (CypA) that was identified in owl monkeys, occurred 4.5-6 million 
years ago (Mya). This TRIM5chimeric protein has potent activity against several retroviruses 
including HIV-1. Another TRIMCyp gene fusion, TRIMCypA2, occurred in macaque species around 
the same time period to generate a second independent TRIM5 chimera. These fusions of TRIM5 
with CypA enhanced the capsid binding activity of TRIM5, giving rise to a novel antiviral defense 
activity. A recent paper published by the Malik and Emerman Labs (Basic Sciences Division) reveals 
two additional TRIMCyp fusions that predateTRIMCypA1 and TRIMCypA2 by nearly 37 million 
years. 
To determine if other TRIMCyp gene fusions existed in primate genomes, Malfavon-Borja et. 
al. sequenced the TRIM5 locus from primate fibroblast cells for the presence of CypA retrogenes. 
Along with CypA2 (present exclusively in macaques), the authors were surprised to discover two 
additional TRIM gene fusions they named CypA3 and CypA4.  Similar to CypA2, CypA3 was present 
in the macaque species examined but was also found in the more ancestral gibbons lineage. Since 
both gibbons and Old World monkeys have CypA3 retrogenes, this suggested that the 
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ancestral CypA3 retrogene was acquired in primates at least 32 Mya based on phylogeny. However, 
further phylogenetic analysis revealed two additional features of this novel gene fusion: 
(1) CypA3was at least 43 million years old and (2) likely functioned for 10 million years before it was 
pseudogenized. 
Given the genomic presence of TRIMCypA3, it was likely that this TRIMCyp gene fusion was 
transcribed to produce a protein with novel anti-viral activity. The researchers probed total mRNA 
isolated from primate fibroblasts by RT-PCR and found TRIMCypA3transcripts from a variety of 
species. Although present, the TRIMCypA3 sequencing data revealed deleterious stop codons 
inTRIMCypA3 from present-day macaques. The presence of pseudogenizing mutations 
in TRIMCypA3  acquired since its birth indicated that its function as a viral restricting factor had 
ceased to be necessary in primates as time advanced. However, the expression of a nearly full-
length TRIMCypA3 transcript in gibbons indicated that the chimeric protein might once have had a 
viral restricting function. 
In a final line of investigation, the researchers expressed the TRIMCyp chimeras in tissue culture 
cells and tested their ability to inhibit viral infection by ancient paleolentiviruses and modern 
lentiviruses (e.g. HIV-1 and HIV-2). For these experiments, owl monkey TRIM5 was fused to 
a CypA3 sequence deemed to be present based on phylogenetic analyses 32 Mya (TRIM5-
32myoCypA3) or to the parental CypA sequence from which CypA3 was derived (TRIM5-parental 
CypA; see figure). Astonishingly, TRIM5-parental CypA displayed a broad and potent antiviral 
activity, but TRIM5-32myoCypA3 did not show antiviral activity against any of the lentiviruses tested. 
These results indicate that the most ancient TRIM5-CypA fusion protein could restrict a broad range 
of retroviruses, but that subsequent evolution refined its activity to a limited number of ancient 
retroviral capsids. Thus, TRIMCyp3 likely arose to combat a viral pathogen encountered by primate 
ancestors 43 Mya. 
Altogether, the research by Bordia et. al. confirm that studying the genetic changes that occurred in 
host retroviral restriction factors throughout evolution can shed light on viral encounters that 
challenged primate health millions of years ago. The techniques and ideas generated by the 
researchers will fuel paleovirology, a burgeoning field of science less than a decade old. When 
asked about future directions of research, Dr. Malik states “We are pursuing other retrogene 
insertions in the human and related genomes. While these have been previously ignored/dismissed 
as pseudogenes, it is clear that among them might reside powerful new antiviral functions." 
Malfavon-Borja R, Wu LI, Emerman M, Malik HS. 2013. Birth, decay, and reconstruction of an 
ancient TRIMCyp gene fusion in primate genomes. Proc Natl Acad Sci. 110: E583–E592. 
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Image obtained from the manuscript 
Genotyping and phylogenetic analysis revealed amino acid changes in parental 
CypA that occurred throughout evolution. Four point mutations in CypA1 
narrowed the broad antiviral activity of parental CypA. With similar logic, 
Malfavon-Borja et. al. argue that the 8 amino acid changes in the novel CypA3 
gene fusion they have identified generated a viral restrictive factor with specificity 
for a limited number of (ancient) viruses. 
 
